{"id":"https://openalex.org/W4200272015","doi":"https://doi.org/10.1093/ofid/ofab466.1533","title":"1341. Relative Vaccine Effectiveness Against Influenza-related Hospitalizations and Respiratory Events During the 2019/20 Influenza seAson in U.S. Children and Adults. A Real-World Evidence Comparison Between Quadrivalent Cell-based and Egg-based Influenza Vaccines","display_name":"1341. Relative Vaccine Effectiveness Against Influenza-related Hospitalizations and Respiratory Events During the 2019/20 Influenza seAson in U.S. Children and Adults. A Real-World Evidence Comparison Between Quadrivalent Cell-based and Egg-based Influenza Vaccines","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W4200272015","doi":"https://doi.org/10.1093/ofid/ofab466.1533"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofab466.1533","doi":"https://doi.org/10.1093/ofid/ofab466.1533","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.1533","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofab466.1533","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030519106","display_name":"Stephen I. Pelton","orcid":"https://orcid.org/0000-0003-4862-5344","observed_orcids":["https://orcid.org/0000-0003-4862-5344"]},"institutions":[{"id":"https://openalex.org/I1286490081","display_name":"Boston Medical Center","ror":"https://ror.org/010b9wj87","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286490081"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen I Pelton","raw_affiliation_strings":["Boston Medical Center, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Medical Center, Boston, Massachusetts","institution_ids":["https://openalex.org/I1286490081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016565734","display_name":"Maarten Jacobus Postma","orcid":"https://orcid.org/0000-0002-6306-3653","observed_orcids":["https://orcid.org/0000-0002-6306-3653"]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Maarten Postma","raw_affiliation_strings":["University of Groningen, Groningen, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Groningen, Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065999728","display_name":"Victoria M. Divino","orcid":"https://orcid.org/0000-0001-5555-7912","observed_orcids":["https://orcid.org/0000-0001-5555-7912"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria Divino","raw_affiliation_strings":["IQVIA, Falls Church, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA, Falls Church, Virginia","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110736746","display_name":"Joaqu\u00edn Federico Mould-Quevedo","orcid":"https://orcid.org/0000-0003-4847-5956","observed_orcids":["https://orcid.org/0000-0003-4847-5956"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joaquin F Mould-Quevedo","raw_affiliation_strings":["Seqirus Vaccines Ltd., Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seqirus Vaccines Ltd., Summit, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029255725","display_name":"Vamshi Ruthwik Anupindi","orcid":"https://orcid.org/0000-0002-0385-8657","observed_orcids":["https://orcid.org/0000-0002-0385-8657"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruthwik Anupindi","raw_affiliation_strings":["IQVIA, Falls Church, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA, Falls Church, Virginia","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011077808","display_name":"Mitch DeKoven","orcid":"https://orcid.org/0000-0001-9346-6202","observed_orcids":["https://orcid.org/0000-0001-9346-6202"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mitchell DeKoven","raw_affiliation_strings":["IQVIA, Falls Church, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA, Falls Church, Virginia","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051264386","display_name":"Myron J. Levin","orcid":"https://orcid.org/0000-0002-7468-106X","observed_orcids":["https://orcid.org/0000-0002-7468-106X"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"myron J levin","raw_affiliation_strings":["University of Colorado Anschutz Medical Campus, Aurora, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Anschutz Medical Campus, Aurora, Colorado","institution_ids":["https://openalex.org/I51713134"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3465,"currency":"USD","value_usd":3465},"apc_paid":{"value":3465,"currency":"USD","value_usd":3465},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"Supplement_1","first_page":"S758","last_page":"S758"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cell-based-influenza-vaccine","display_name":"cell-based influenza vaccine","score":0.8479999899864197},{"id":"https://openalex.org/keywords/quadrivalent-influenza-vaccine","display_name":"quadrivalent influenza vaccine","score":0.9679999947547913},{"id":"https://openalex.org/keywords/relative-vaccine-effectiveness","display_name":"relative vaccine effectiveness","score":0.8169999718666077},{"id":"https://openalex.org/keywords/influenza-related-hospitalization","display_name":"influenza-related hospitalization","score":0.8230000138282776},{"id":"https://openalex.org/keywords/emergency-department-visits","display_name":"emergency department visits","score":0.906000018119812},{"id":"https://openalex.org/keywords/vulnerable-populations","display_name":"vulnerable populations","score":0.49799999594688416},{"id":"https://openalex.org/keywords/children-and-adults","display_name":"children and adults","score":0.734000027179718},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.5389999747276306},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6330000162124634},{"id":"https://openalex.org/keywords/inverse-probability-of-treatment-weighting","display_name":"inverse probability of treatment weighting","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8592337369918823},{"id":"https://openalex.org/C2780689484","wikidata":"https://www.wikidata.org/wiki/Q383260","display_name":"Influenza vaccine","level":3,"score":0.7107827663421631},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.6080254912376404},{"id":"https://openalex.org/C73269764","wikidata":"https://www.wikidata.org/wiki/Q954529","display_name":"Poisson regression","level":3,"score":0.6074610352516174},{"id":"https://openalex.org/C2780724011","wikidata":"https://www.wikidata.org/wiki/Q1295316","display_name":"Emergency department","level":2,"score":0.5190997123718262},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4476074278354645},{"id":"https://openalex.org/C2776012195","wikidata":"https://www.wikidata.org/wiki/Q754447","display_name":"Respiratory tract infections","level":3,"score":0.42469578981399536},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.40792569518089294},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3384297490119934},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.2950765788555145},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.2915458679199219},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.15825700759887695},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.06904739141464233},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ofid/ofab466.1533","doi":"https://doi.org/10.1093/ofid/ofab466.1533","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.1533","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofab466.1533","doi":"https://doi.org/10.1093/ofid/ofab466.1533","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.1533","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200063352","https://openalex.org/W3046094430","https://openalex.org/W4406951934","https://openalex.org/W3026050423","https://openalex.org/W4284883884","https://openalex.org/W4304689381","https://openalex.org/W3125941622","https://openalex.org/W4396589876","https://openalex.org/W7122386979","https://openalex.org/W4414775225"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Non-egg-based":[2],"influenza":[3,25,38,60,139,175],"vaccine":[4,16,26,30,39],"manufacturing":[5],"reduces":[6],"egg":[7],"adaptation":[8],"and":[9,46,110,123,179,219,272],"therefore":[10],"has":[11],"the":[12,22,42,58,83,106,145,173,234,259],"potential":[13],"to":[14,34,100,132,203,243,282],"increase":[15],"effectiveness.":[17],"This":[18],"study":[19,146],"evaluated":[20],"whether":[21],"cell-based":[23],"quadrivalent":[24,37],"(QIVc)":[27],"improved":[28],"relative":[29],"effectiveness":[31],"(rVE)":[32],"compared":[33,202,242,281],"standard-dose":[35],"egg-based":[36],"(QIVe-SD)":[40],"in":[41,82,269],"reduction":[43],"of":[44,86,94,108,116,323],"influenza-related":[45,117,206,246,271],"respiratory-related":[47,120,221,273],"hospitalizations/emergency":[48],"room":[49],"(ER)":[50],"visits":[51,122,208,248],"among":[52,68],"subjects":[53,69],"4-64":[54,70],"years":[55,71,190],"old":[56,72],"during":[57],"2019/20":[59,174],"season.":[61],"Methods":[62],"A":[63,151,228],"retrospective":[64],"analysis":[65],"was":[66,98,130,157,164,195,231,249,256,265],"conducted":[67],"vaccinated":[73,114],"with":[74,142,197],"QIVc":[75,178,194,241,264],"or":[76,328],"QIVe-SD":[77,181,204,244],"using":[78],"administrative":[79],"claims":[80],"data":[81],"United":[84],"States":[85],"America":[87],"(U.S.)":[88],"(IQVIA":[89],"PharMetrics\u00ae":[90],"Plus).":[91],"Inverse":[92],"probability":[93],"treatment":[95],"weighting":[96],"(IPTW)":[97],"used":[99,131],"adjust":[101],"for":[102,153,233,237,240,258],"baseline":[103],"confounders.":[104],"Post-IPTW,":[105],"number":[107],"events":[109],"rates":[111],"(per":[112],"1,000":[113],"subject-seasons)":[115],"hospitalizations/ER":[118,121,207,247,274],"visits,":[119,275],"all-cause":[124,213,279],"hospitalizations":[125,214],"were":[126,183],"assessed.":[127],"Poisson":[128],"regression":[129],"estimate":[133],"adjusted":[134,187],"rVE.":[135],"To":[136],"avoid":[137],"any":[138,220],"outcome":[140],"misclassification":[141],"COVID-19":[143],"infection,":[144],"period":[147],"ended":[148],"March":[149],"7,2020.":[150],"sub-analysis":[152],"a":[154,167,198],"high-risk":[155,235],"subgroup":[156],"conducted.":[158],"Urinary":[159],"tract":[160],"infection":[161],"(UTI)":[162],"hospitalization":[163],"assessed":[165],"as":[166,276,278],"negative":[168,260],"control":[169,261],"endpoint.":[170],"Results":[171],"During":[172],"season,":[176],"1,150,134":[177],"3,924,819":[180],"recipients":[182],"identified":[184,257],"post-IPTW.":[185],"Overall":[186],"analyses":[188],"(4-64":[189],"old)":[191],"found":[192],"that":[193],"associated":[196],"significantly":[199,266],"higher":[200],"rVE":[201,239],"against":[205,245],"(5.3%":[209],"[95%":[210,216,225,251],"CI:":[211,217,226,252],"0.5%-9.9%]),":[212],"(14.5%":[215],"13.1%-15.8%])":[218],"hospitalization/ER":[222],"visit":[223],"(8.2%":[224],"6.5%-9.8%]).":[227],"similar":[229],"trend":[230],"seen":[232],"subgroup;":[236],"instance,":[238],"10.5%":[250],"2.9%-17.4%].":[253],"No":[254],"effect":[255],"outcome.":[262],"Conclusion":[263],"more":[267],"effective":[268],"preventing":[270],"well":[277],"hospitalizations,":[280],"QIVe-SD.":[283],"Disclosures":[284],"Stephen":[285],"I.":[286],"Pelton,":[287],"MD,":[288,320],"Seqirus":[289,294,299,305,310,315],"(Consultant)":[290,295,300,311,316],"Maarten":[291],"Postma,":[292],"Dr.,":[293],"Victoria":[296],"Divino,":[297],"PhD,":[298,304,309,314],"Joaquin":[301],"F.":[302],"Mould-Quevedo,":[303],"(Employee)":[306],"Ruthwik":[307],"Anupindi,":[308],"Mitchell":[312],"DeKoven,":[313],"myron":[317],"J.":[318],"levin,":[319],"GSK":[321],"group":[322],"companies":[324],"(Employee,":[325],"Research":[326],"Grant":[327],"Support)":[329]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2021-12-31T00:00:00"}